Research Article
Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
Table 1
Changes in general characteristics before and after 14 weeks of treatment with DHM in STZ-induced diabetic mice.
| |||||||||||||||||||||||||||||||||||||||||||||
The data are presented as means and SD (). versus CON; versus CON + DHM; versus DM. |